Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Profit Margin (Quarterly) : 23.59% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.59% |
| March 31, 2026 | 21.02% |
| December 31, 2025 | 13.47% |
| September 30, 2025 | 33.55% |
| June 30, 2025 | 15.62% |
| March 31, 2025 | 21.38% |
| December 31, 2024 | 6.93% |
| September 30, 2024 | 33.46% |
| June 30, 2024 | 8.95% |
| March 31, 2024 | -1.53% |
| December 31, 2023 | 9.43% |
| September 30, 2023 | 25.18% |
| June 30, 2023 | 19.84% |
| March 31, 2023 | 46.94% |
| December 31, 2022 | 23.92% |
| September 30, 2022 | 32.55% |
| June 30, 2022 | 20.13% |
| March 31, 2022 | 23.76% |
| December 31, 2021 | 27.80% |
| September 30, 2021 | 28.07% |
| June 30, 2021 | 7.09% |
| March 31, 2021 | 27.89% |
| December 31, 2020 | 24.42% |
| September 30, 2020 | 31.67% |
| June 30, 2020 | 29.37% |
| Date | Value |
|---|---|
| March 31, 2020 | 29.86% |
| December 31, 2019 | 27.66% |
| September 30, 2019 | 34.46% |
| June 30, 2019 | 37.25% |
| March 31, 2019 | 35.94% |
| December 31, 2018 | 31.10% |
| September 30, 2018 | 31.50% |
| June 30, 2018 | 37.77% |
| March 31, 2018 | 41.36% |
| December 31, 2017 | -73.20% |
| September 30, 2017 | 35.00% |
| June 30, 2017 | 37.23% |
| March 31, 2017 | 38.30% |
| December 31, 2016 | 32.80% |
| September 30, 2016 | 35.11% |
| June 30, 2016 | 33.34% |
| March 31, 2016 | 34.98% |
| December 31, 2015 | 32.99% |
| September 30, 2015 | 33.05% |
| June 30, 2015 | 31.31% |
| March 31, 2015 | 32.70% |
| December 31, 2014 | 24.38% |
| September 30, 2014 | 24.75% |
| June 30, 2014 | 29.86% |
| March 31, 2014 | 23.73% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -134.2% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
| AbbVie, Inc. | 21.21% |
| Biogen, Inc. | 3.72% |
| Vertex Pharmaceuticals, Inc. | 32.89% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 93.84% |
| Return on Assets | 9.57% |
| Return on Invested Capital | 13.35% |
| Gross Profit Margin (Quarterly) | 72.08% |
| Operating Margin (Quarterly) | 35.04% |
| Return on Net Operating Assets | 13.44% |